8.3204
price up icon2.64%   0.1904
 
loading

Finanzdaten der Kura Oncology Inc-Aktie (KURA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.36%
15.29
14.11 - - -
Operating Expenses
11.61%
87.95
78.81 59.88 56.40 54.45
Benefits Costs and Expenses
14.16%
81.41
71.31 - - -
Costs And Expenses
14.16%
81.41
71.31 - - -
Operating Income/Loss
12.31%
-72.67
-64.70 - - -
Nonoperating Income/Loss
12.71%
6.544
7.497 5.48 5.567 4.927
Income/Loss From Continuing Operations Before Tax
15.59%
-66.12
-57.20 -54.40 -50.84 -49.52
Income Tax Expense/Benefit
100.00%
-
0.226 - - -
Income/Loss From Continuing Operations After Tax
15.14%
-66.12
-57.43 -54.40 -50.84 -49.52
Net Income/Loss
15.14%
-66.12
-57.43 -54.40 -50.84 -49.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.20%
87.59
87.42 86.95 86.64 83.91
Diluted Average Shares
0.20%
87.59
87.42 86.95 86.64 83.91
Basic Earnings Per Share
13.64%
-0.75
-0.66 -0.63 -0.59 -0.59
Diluted Earnings Per Share
13.64%
-0.75
-0.66 -0.63 -0.59 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.73
price up icon 0.23%
$27.55
price up icon 0.58%
$24.41
price up icon 3.64%
$110.50
price up icon 7.16%
$140.65
price down icon 0.69%
biotechnology ONC
$338.19
price up icon 6.55%
Kapitalisierung:     |  Volumen (24h):